Quantifying asbestos in lung tissue: what debate?

Benoit Nemery, Valerie Nuyts, Kristiaan Nackaerts

Source: Eur Respir J, 49 (6) 1700861; 10.1183/13993003.00861-2017
Journal Issue: June

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Benoit Nemery, Valerie Nuyts, Kristiaan Nackaerts. Quantifying asbestos in lung tissue: what debate?. Eur Respir J, 49 (6) 1700861; 10.1183/13993003.00861-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The asbestos fibre burden in human lungs: new insights into the chrysotile debate
Source: Eur Respir J, 49 (6) 1602534; 10.1183/13993003.02534-2016
Year: 2017



Correspondence regarding the article “The asbestos fibre burden in human lungs: new insights into the chrysotile debate”
Source: Eur Respir J, 50 (6) 1702188; 10.1183/13993003.02188-2017
Year: 2017



Correspondence regarding the article “The asbestos fibre burden in human lungs: new insights into the chrysotile debate”
Source: Eur Respir J, 50 (6) 1701644; 10.1183/13993003.01644-2017
Year: 2017



Correspondence regarding the article “The asbestos fibre burden in human lungs: new insights into the chrysotile debate”
Source: Eur Respir J, 50 (6) 1702204; 10.1183/13993003.02204-2017
Year: 2017



Asbestos and the lung: highlights of a detrimental relationship
Source: Breathe, 13 (3) 235; 10.1183/20734735.010017
Year: 2017



Cadmium in tobacco smokers: a neglected link to lung disease?
Source: Eur Respir Rev, 27 (147) 170122; 10.1183/16000617.0122-2017
Year: 2018



Lung cancer and mineralogical analysis of asbestos bodies in lung tissue
Source: Eur Respir J 2007; 30: Suppl. 51, 159s
Year: 2007

Action levels for indoor radon: different risks for the same lung carcinogen?
Source: Eur Respir J, 50 (5) 1701609; 10.1183/13993003.01609-2017
Year: 2017



The lung cancer microenvironment and the lung microbioma: cross or cease fire?
Source: Virtual Congress 2020 – Exciting new developments in lung cancer screening, diagnostics and treatment
Year: 2020

Cellular plasticity in lung fibrosis: where are all the fibroblasts coming from?
Source: Annual Congress 2012 - PG11 Pulmonary fibrosis
Year: 2012



Diffuse parenchymal lung disease: a practical overview Is a lung biopsy necessary for management?
Source: Breathe 2008; 4: 233-239
Year: 2008


Microplastics inhalation: evidence in human lung tissue
Source: Virtual Congress 2021 – Environment and air pollution
Year: 2021

Targeting the lung epithelium: does age matter?
Source: Virtual Congress 2020 – The ageing lung epithelium: effects on repair and regeneration
Year: 2020


Lung ageing and COPD: is there a role for ageing in abnormal tissue repair?
Source: Eur Respir Rev, 26 (146) 170073; 10.1183/16000617.0073-2017
Year: 2017



Lung tissue engineering: making a functional human lung
Source: International Congress 2016 – Regeneratives approaches to COPD
Year: 2016


Mortality in interstitial lung disease: do race and skin colour matter?
Source: Eur Respir J, 51 (6) 1800892; 10.1183/13993003.00892-2018
Year: 2018



“Lung sparing growth”: is the lung not affected by malnutrition?
Source: Eur Respir J , 49 (4) 1700295; DOI: 10.1183/13993003.00295-2017
Year: 2017


Fibrotic interstitial lung diseases and air pollution: a systematic literature review
Source: Eur Respir Rev, 29 (157) 200093; 10.1183/16000617.0093-2020
Year: 2020



What’s new in interstitial lung diseases in children?
Source: Virtual Congress 2021 – Paediatric year in review
Year: 2021


Artificial intelligence  in lung cancer: where are we now?
Source: Virtual Congress 2020 – Imaging grand round
Year: 2020